This is the authors' abstract. We don't add key points for this paper.
have a narrow host range and target members from only one or a few PCR ribotypes. Without a clear comprehension of the factors that define host specificity, and in particular the host receptor recognized by phages, it is hard to develop therapeutic cocktails in a rational manner. In our study, we provide clear and unambiguous experimental evidence that SlpA is a common receptor used by many siphophages and myophages. Although work is still needed to define how a particular phage receptor-binding protein binds to a specific SLCT, the identification of SlpA as a common receptor is a major keystone that will facilitate the rational design of therapeutic phage cocktails against clinically important strains.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Royer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: